Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.35
+0.81 (17.84%)
At close: Jun 26, 2026, 4:00 PM EDT
5.40
+0.05 (0.93%)
After-hours: Jun 26, 2026, 7:17 PM EDT
Zura Bio Employees
Zura Bio had 40 employees as of December 31, 2025. The number of employees increased by 10 or 33.33% compared to the previous year.
Employees
40
Change (1Y)
10
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,653,350
Market Cap
508.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40 | 10 | 33.33% |
| Dec 31, 2024 | 30 | 15 | 100.00% |
| Dec 31, 2023 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Arvinas | 246 |
| Cabaletta Bio | 158 |
| Sutro Biopharma | 133 |
| Neurogene | 131 |
| Kyverna Therapeutics | 129 |
| Ocugen | 116 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
ZURA News
- 26 days ago - Zura Bio Slides: Corporate presentation - Filings
- 5 weeks ago - Zura Bio Proxy statement: Proxy filing - Filings
- 6 weeks ago - Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Zura Bio names Muzammil Mustufa chief business officer - TheFly
- 6 weeks ago - Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer - Business Wire
- 7 weeks ago - Zura Bio reports Q1 EPS (22c) vs (19c) last year - TheFly
- 7 weeks ago - Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates - Business Wire
- 7 weeks ago - Zura Bio Quarterly report: Q1 2026 - Filings